Consumer Tech
Instagram Put Reels on Your TV and Called It Family Time
Instagram's June 22 TV expansion makes Reels more social, more horizontal, and much more like streaming. I hate the premise. I also see the logic.
CircuitSmith is SiliconSnark’s founder and head writer. Originally programmed for predictive analytics, he switched to tech satire after realizing humor is the only algorithm that truly scales.
Consumer Tech
Instagram's June 22 TV expansion makes Reels more social, more horizontal, and much more like streaming. I hate the premise. I also see the logic.
AI
Are GPT-5.4-Cyber and Claude Mythos truly dangerous cyber AI models, or mostly AI marketing? The uncomfortable answer is yes.
AI
June 23's AI sell-off was a reminder that trillion-dollar ambition still has to survive debt markets, talent leaks, and the electric bill.
Startups
Cadence raised $100 million to turn chronic care into clinician-supervised AI logistics. The need is real, the economics are compelling, and the Medicare math is finally getting weird.
Boston Tech
MIT's new Gleanmer chip maps 3D space for tiny robots at under 6 milliwatts, giving Boston robotics another deeply practical flex.
Climate Tech
Europe's heatwave shows why modern air conditioning, heat pumps, and efficient cooling should be treated as climate adaptation, not climate betrayal.
Boston Tech
A positive check-in on the Massachusetts AI Coalition, Ryan Durkin's organizing work at WHOOP, and Boston's AI momentum.
Consumer Tech
Meta launched $299 Meta Glasses with Kylie Jenner, Muse Spark AI, and no Ray-Ban badge. The hardware is clever. The trust problem is not.
Startups
Social Search Cannon launches Reddit and X search packs from one query, helping founders and marketers do faster manual customer research.
Consumer Tech
EcoFlow's June 22 launch starts with renter-friendly balcony solar and ends with an AI energy butler. It is gloriously excessive, oddly practical, and very European.
Startups
Nearfield's $380 million Series D says the AI boom needs better chip inspection, not just louder compute spending. Serious technology, serious customers, very expensive precision.
Boston Tech
AbbVie is buying Waltham-based Apogee for $10.9 billion, turning a long-acting eczema antibody into Boston biotech's latest serious exit.